Slide 1: Presentation Half-year results 2018
DKSH Holding Ltd. Presentation Half-year results 2018
Slide 2: Overview Half-Year 2018
Overview Half-Year 2018 Net sales grew by 7.4% Profit after tax increases 4.5% EBIT on last year’s level Increased performance in Healthcare, Performance Materials and Technology Investments and initiatives in Business Unit Consumer Goods impact result Increased strategic focus Page 2 © DKSH 2018
Slide 3: Growth drivers in H1 2018
Growth drivers in H1 2018 Net sales (in CHF million) Continued growth • Organic growth rate of 3.7% +3.1% +0.6% • M&A contributed 0.6% to growth +3.7% • Positive FX-impact of 3.1% Net sales split by region (in %) Thailand • Onboarding of several Asian consumer brands Thailand 4.1% • Good demand in h
Slide 4: Adjustments in Business Unit Consumer Goods
Adjustments in Business Unit Consumer Goods • Expanded route-to-market • Return to net sales growth approach • Costs to upgrade and • Transport-management- Key account Route-to-market expand team system management • Integration of PT • Well-accepted omni- Wicaksana into DKSH channel offering • Conti
Slide 5: DKSH Group
DKSH Group Change in CHF million H1 2018 H1 2017 % CHF % at CER¹ Net sales 5,671.1 5,278.7 7.4 4.3 Operating profit (EBIT) 139.5 138.8 0.5 (3.0) Profit after tax 97.5 93.3 4.5 0.4 Free Cash Flow (in CHF million) RONOC (in %) Number of specialists 69.6 24.2 30,890 32,050 22.1 56.7 H1 2017 H1 2018 H1
Slide 6: Consumer Goods
Business Unit Consumer Goods
Slide 7: Business Unit Consumer Goods
Business Unit Consumer Goods Net sales (in CHF million) Return to net sales growth 1,920.7 • Indochina region with strong growth 9.4% • Intensified key account management with focus on Asian brands 1,755.1 H1 2017 H1 2018 EBIT (in CHF million) EBIT below prior year’s level • Higher costs for key acc
Slide 8: Healthcare
Nwuns) IWUNY? Pharmacy Pharmacy Business Unit Healthcare
Slide 9: Business Unit Healthcare
Business Unit Healthcare Net sales (in CHF million) Continued solid demand for healthcare in Asia • Good growth across markets in South East Asia • Further good potential in various healthcare markets 3,082.9 6.7% across Asia 2,888.4 H1 2017 H1 2018 EBIT (in CHF million) Further EBIT growth • EBIT i
Slide 10: Performance Materials
Business Unit Performance Materials
Slide 11: Business Unit Performance Materials
Business Unit Performance Materials Net sales (in CHF million) Solid sales growth • South East Asia with good growth, especially in 475.7 Thailand, Philippines and India 5.8% 449.6 • In Europe, too, good performance H1 2017 H1 2018 EBIT (in CHF million) Strong EBIT growth 39.7 • EBIT grew by 6.1% in
Slide 12: Technology
Business Unit Technology
Slide 13: Business Unit Technology
Business Unit Technology Net sales (in CHF million) Slightly higher net sales • Net sales growth of 3.3% 192.1 • Good demand in Japan, Thailand and Indonesia 3.3% 185.9 H1 2017 H1 2018 EBIT (in CHF million) Higher EBIT • EBIT increases by 52.6% 8.7 • First half of 2018 with larger contract wins in J
Slide 14: Increased strategic focus
Increased strategic focus Focus on existing Business Units Strengthen service offering Increase operational efficiency Key Account Route-to-Market Digital Regulatory Automation Transport Management systems Page 14 © DKSH 2018
Slide 15: Outlook for 2018
Outlook for 2018 Long-term growth drivers remain intact Further growth in net sales Operating result around last year's level Continuation of progressive dividend policy Page 15 © DKSH 2018
Slide 16: Disclaimer
Disclaimer Due care has been used in preparation of this presentation and DKSH makes every effort to provide accurate and up-to-date information. Nevertheless, this presentation may be subject to technical inaccuracies, information that is not up-to-date or typographical errors. DKSH does not assume